COMMUNIQUÉS West-GlobeNewswire

VBI Vaccines Announces Voluntary Delisting from the Toronto Stock Exchange
12/03/2018
CAMBRIDGE, Mass., March 12, 2018 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. ("VBI" or the "Company") (Nasdaq: VBIV ) (TSX: VBV ), a commercial-stage biopharmaceutical company developing next-generation infectious disease and [...]
Agile Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results
12/03/2018
PRINCETON, N.J., March 12, 2018 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX ), a women's healthcare company, today reported financial results for the three months and year ended December 31, 2017 and [...]
Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Fiscal Year Ended December 31, 2017
12/03/2018
RANCHO CUCAMONGA, Calif., March 12, 2018 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH ) (“Amphastar” or the “Company”) today reported results for the three months and fiscal year ended December 31, [...]
Proteostasis Therapeutics Announces FDA Grants Breakthrough Therapy Designation for PTI-428 in Cystic Fibrosis
12/03/2018
CAMBRIDGE, Mass., March 12, 2018 (GLOBE NEWSWIRE) -- Proteostasis Therapeutics, Inc. (NASDAQ: PTI ), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to [...]
Prothena to Present a Broad Range of Scientific and Health Outcomes Data at the 16th International Symposium on Amyloidosis
12/03/2018
DUBLIN, Ireland, March 12, 2018 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq: PRTA ), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel therapies in [...]
Crinetics Pharmaceuticals Announces Upcoming Presentations at ENDO 2018
12/03/2018
SAN DIEGO, March 12, 2018 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc., a rare disease therapeutics company focused on endocrine disorders and endocrine-related cancers, today announced an oral presentation and [...]
Aquinox Pharmaceuticals Announces Year End 2017 Financial Results
12/03/2018
VANCOUVER, British Columbia, March 12, 2018 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals , Inc. (" Aquinox ") (NASDAQ: AQXP ), a clinical-stage pharmaceutical company discovering and developing novel drug candidates to [...]
G1 Therapeutics Announces Closing of Offering of Common Stock
12/03/2018
RESEARCH TRIANGLE PARK, N.C., March 12, 2018 (GLOBE NEWSWIRE) -- G1 Therapeutics, Inc. (Nasdaq: GTHX ), a clinical-stage oncology company, today announced the closing of an underwritten public offering of 3,910,000 [...]
Kura Oncology Provides Regulatory Update on Tipifarnib and Reports Fourth Quarter and Full Year 2017 Financial Results
12/03/2018
– Company plans to initiate registration-directed trial of tipifarnib in second half of 2018 following recent end of Phase 2 meeting with the FDA – – Single-arm trial to enroll at least 59 recurrent or metastatic HRAS [...]
Avid Bioservices Reports Financial Results for Third Quarter of Fiscal Year 2018 and Recent Developments
12/03/2018
Company Remains on Target for Full Year Revenue of $50.0 - $55.0 Million Intensified Business Development Effort Results in New Customer Contract and Strengthened Backlog TUSTIN, Calif., March 12, 2018 (GLOBE NEWSWIRE [...]
Tabula Rasa HealthCare Announces Fourth Quarter and Full Year 2017 Operating Results
12/03/2018
2017 Revenue of $134.5 million, growth of 43%; 4Q 2017 Revenue of $43.9 million, growth of 61% Provides initial 2018 financial outlook MOORESTOWN, N.J., March 12, 2018 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (“ [...]
Positive Phase 1/2 Results of AKCEA-APOCIII-LRx Presented at American College of Cardiology Annual Scientific Session & Expo
12/03/2018
CAMBRIDGE, Mass. and CARLSBAD, Calif. , March 12, 2018 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ: AKCA ), an affiliate of Ionis Pharmaceuticals, Inc. (NASDAQ: IONS ), and Ionis Pharmaceuticals, Inc., today [...]
Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results
12/03/2018
-- Continuing Enrollment in Pivotal Phase 3 Clinical Trial of Setmelanotide in Pro-Opiomelanocortin (POMC) Deficiency Obesity; On Track to Complete Enrollment of 10 Patients in First Half of 2018 -- -- Enrolled First [...]
Iovance Biotherapeutics Reports Fourth Quarter and Full-Year 2017 Financial Results and Provides Corporate Update
12/03/2018
SAN CARLOS, Calif., March 12, 2018 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA ), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocyte (TIL) [...]
Adherium’s Directors Purchase Approximately 1.4 Million Shares on the Open Market
12/03/2018
SAN MATEO, Calif., March 12, 2018 (GLOBE NEWSWIRE) -- Adherium (ASX:ADR), a digital health company that improves medication adherence and patient outcomes, today announced that members of its Board of Directors recently [...]
IntelGenx Clarifies Recent Preliminary 2018 Proxy Statement Filing
12/03/2018
SAINT LAURENT, Quebec, March 12, 2018 (GLOBE NEWSWIRE) -- In response to investor inquiries received about its preliminary proxy statement, filed with the U.S. Securities and Exchange Commission on March 7, 2018, [...]
Kiadis Pharma N. V.: CORRECTION (Includes Disclaimers) Kiadis Pharma launches a private placement of approximately 2.6 million new shares
12/03/2018
Not for release, publication or distribution, directly or indirectly, in or into the United States, Australia, Canada, Japan, south africa or Any other jurisdiction in which such release, publication or distribution [...]
Kiadis Pharma N. V.: Kiadis Pharma launches a private placement of approximately 2.6 million new shares
12/03/2018
Kiadis Pharma launches a private placement of approximately 2.6 million new shares Amsterdam, The Netherlands, March 12, 2018 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam and Brussels: KDS [...]
Annual General Meeting in ALK-Abelló A/S held on 12 March 2018
12/03/2018
Copenhagen, 2018-03-12 17:22 CET (GLOBE NEWSWIRE) -- ALK ( ALKB:DC / OMX: ALK B / AKABY / AKBLF ) held its annual general meeting on 12 March 2018. The annual general meeting transacted the following business: Adoption [...]

Pages